Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study

被引:0
作者
Einav Ratzon
Yousef Najajreh
Rami Salem
Hazem Khamaisie
Martin Ruthardt
Jamal Mahajna
机构
[1] Cancer Drug Discovery Program,Anticancer Drugs Research Lab, Faculty of Pharmacy
[2] Migal,The Department of Nutritional Sciences
[3] Galilee Research Institute,undefined
[4] Al-Quds University,undefined
[5] Medizinische Klinik II/Abtl. Hämatologie,undefined
[6] Klinikum der Johann Wolfgang Goethe Universität,undefined
[7] Tel Hai College,undefined
来源
BMC Cancer | / 16卷
关键词
Platinum (IV); Cisplatin; Ovarian cancer; Resistance; Copper transporter (Ctr1);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 95 条
  • [41] McKeage MJ(undefined)undefined undefined undefined undefined-undefined
  • [42] Gibbons GR(undefined)undefined undefined undefined undefined-undefined
  • [43] Wyrick S(undefined)undefined undefined undefined undefined-undefined
  • [44] Chaney SG(undefined)undefined undefined undefined undefined-undefined
  • [45] Ruimi N(undefined)undefined undefined undefined undefined-undefined
  • [46] Rwashdeh H(undefined)undefined undefined undefined undefined-undefined
  • [47] Wasser S(undefined)undefined undefined undefined undefined-undefined
  • [48] Konkimalla B(undefined)undefined undefined undefined undefined-undefined
  • [49] Efferth T(undefined)undefined undefined undefined undefined-undefined
  • [50] Hannun YA(undefined)undefined undefined undefined undefined-undefined